Regenerative Dermatology Company Successfully Applies “Injury Mimetic” Stimulated Stem Cell Grafts to Treatment of Third Largest Cause of Death in USA SAN DIEGO, Dec. 31, 2024 /PRNewswire/ — Robles BioCeutics announced new data demonstrating protection [...]SAN DIEGO, Dec. 31, 2024 /PRNewswire/ — CreateAI Holdings Inc., formerly TuSimple Holdings Inc. (OTCMKTS: TSPH) (“CreateAI” or the “Company”), a global artificial intelligence technology company, today announced that its Board of Directors (the “Board”) [...]Research Assistant I will work as a part of a team that studies how cytoskeletal motor protein complexes are… Click here to view original postSAN DIEGO, Dec. 30, 2024 /PRNewswire/ — Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Caribou Biosciences, Inc. (NASDAQ: CRBU) securities [...]The new brand campaign kickstarts the new year, empowering members to take their health to the next level at a critical time of renewal and enthusiasm. CARLSBAD, Calif., Dec. 30, 2024 /PRNewswire/ — 24 Hour [...]SAN DIEGO, Dec. 30, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Takeda received regulatory approval for HYQVIA® [Immune Globulin Infusion 10% (Human) with Halozyme’s Recombinant Human Hyaluronidase] by the Japanese [...]Job Summary Join our dynamic team of Scientists and Research Associates, where you’ll lead cutting-edge product development of RUO… Click here to view original postOpdivo Qvantig represents the first and only subcutaneously administered PD-1 inhibitor Opdivo Qvantig demonstrated consistent efficacy and showed a comparable safety profile to IV Opdivo in the Phase 3 CheckMate-67T trial SAN DIEGO, Dec. 30, [...]SAN DIEGO, Dec. 30, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx’s VYVDURA (efgartigimod alfa and hyaluronidase-qvfc), which is co-formulated with Halozyme’s ENHANZE® drug delivery technology, was granted regulatory approval [...]Profile insights Find out how your skills align with the job description Skills Do you have experience in Research? Education Do you have a Master’s… Click here to view original postProfile insights Find out how your skills align with the job description Skills Do you have experience in Research? Education Do you have a Master’s… Click here to view original postFiling Deadline: Thu 1/9/2025 UC San Diego values equity, diversity, and inclusion. If you are interested in… Click here to view original postProfile insights Find out how your skills align with the job description Skills Do you have experience in SolidWorks? 401(k) 4% Match 401(k) matching Dental insurance Health… Click here to view original postSAN DIEGO, Dec. 27, 2024 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December [...]SAN DIEGO, Dec. 26, 2024 /PRNewswire/ — Robbins LLP reminds investors that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain of the Company’s senior executives and directors who signed [...]SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that its [...]SAN DIEGO, Dec. 26, 2024 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Capri Holdings Limited (NYSE: CPRI) stock or sellers of Capri puts between August 10, [...]SAN DIEGO, Dec. 26, 2024 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of AstraZeneca PLC (NASDAQ: AZN) publicly traded securities between February 23, 2022 and [...]Filing Deadline: Mon 1/6/2025 UC San Diego values equity, diversity, and inclusion. If you are interested in… Click here to view original postFiling Deadline: Mon 1/6/2025 UC San Diego values equity, diversity, and inclusion. If you are interested in… Click here to view original postProfile insights Find out how your skills align with the job description Skills Do you have experience in Laboratory experience? Education Do you have a… Click here to view original postSAN DIEGO, Dec. 23, 2024 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, announced today the relocation of the Company’s headquarters from San Diego, California to Cary, North [...]Promising BRACELET-1 results in HR+/HER2- metastatic breast cancer lay the foundation for potential registration-enabling study and accelerated approval Advancing gastrointestinal cancer pipeline underscores potential for additional registration-enabling studies SAN DIEGO and CALGARY, AB,… Click here [...]Why join Ajinomoto Bio-Pharma? Our mission is to help improve the health of humankind. We are a fully… Click here to view original postWhy join Ajinomoto Bio-Pharma? Our mission is to help improve the health of humankind. We are a fully… Click here to view original postWhy join Ajinomoto Bio-Pharma? Our mission is to help improve the health of humankind. We are a fully… Click here to view original post2024 had its dazzling moments, but, in the end, it was a year of treading water for biopharma stocks, judging from the top three electronic transfer funds (ETFs) specializing in such shares. The iShares Biotechnology [...]Profile insights Find out how your skills align with the job description Skills Do you have experience in Supervising experience? Education Do you have a… Click here to view original post